Royalty Pharma plc (NASDAQ:RPRX) Q3 2020 Results Conference Call November 11, 2020 8:00 AM ET
Company Participants
George Grofik - SVP, Head, IR and Communications
Pablo Legorreta - Founder and CEO
Jim Reddoch - EVP and Head of Research & Investments
Terry Coyne - EVP and CFO
Chris Hite - Vice Chairman
Marshall Urist - SVP, Research and Investments
Conference Call Participants
Geoff Meacham - Bank of America
Steve Scala - Cowen
David Risinger - Morgan Stanley
Chris Schott - JP Morgan
Greg Gilbert - Truist
Navin Jacob - UBS
Michael DiFiore - Evercore
Terence Flynn - Goldman Sachs
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2020 Earnings Conference Call.
I would now like to turn the call over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.
George Grofik
Thank you, Shannon. And good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma’s third quarter results. You can find the slides to this call on the Investors page of our website at royaltypharma.com.
Moving to slide three, I would like to remind you that information presented in this call contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our S-1, Prospectus on file with the SEC for a description of these risk factors.
And with that, please advance to slide 4. Our speakers on the call today are; Pablo Legorreta, Founder and Chief Executive Officer; Jim Reddoch, EVP, Head of Research & Investments; and Terry Coyne, EVP, Chief Financial Officer. Pablo will discuss the key highlights of the quarter after which Jim will provide an update on our Royalty portfolio. Terry will then review the financials. And after concluding remarks from Pablo, we will
- Read more current RPRX analysis and news
- View all earnings call transcripts